Xinqiao Hospital Of Chongqing
Clinical trials sponsored by Xinqiao Hospital Of Chongqing, explained in plain language.
-
New mRNA shot tested to fight Virus-Linked cancers
Disease control Not yet recruitingThis early-stage study is testing a new type of treatment called mRNA immunotherapy for cancers caused by the Epstein-Barr virus (EBV), like some lymphomas and stomach cancers. It will be given to about 40 adults, either by itself or combined with another immunotherapy drug. The …
Phase: EARLY_PHASE1 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New mRNA tech targets stubborn autoimmune diseases
Disease control Not yet recruitingThis early-stage study is testing a new mRNA therapy designed to treat several autoimmune diseases that haven't responded well to other treatments. The therapy uses technology similar to some COVID-19 vaccines to deliver instructions that target a specific part of the immune syst…
Phase: EARLY_PHASE1 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Breakthrough trial aims to boost stroke recovery when time is critical
Disease control Not yet recruitingThis study is testing whether adding a medication called eptifibatide helps people recover better after receiving standard clot-busting treatment for a stroke. It focuses on patients who get treatment 4.5 to 24 hours after symptoms begin and who aren't improving well. The main go…
Phase: PHASE3 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Mar 02, 2026 15:21 UTC